What Can You Expect at the Nasal Formulation & Delivery Summit?
The 4th Nasal Formulation & Delivery Summit united leaders across large pharma, biotechs, device developers and academia all advancing intranasal therapies across systemic, CNS, emergency-use, and infectious disease indications. This industry-focused meeting was built to tackle the formulation, delivery, and development challenges shaping today’s intranasal pipeline.
Across expert-led presentations, interactive workshops, and data-driven case studies, hear how teams from Eli Lilly, Neurelis, Virpax Pharmaceuticals, Belhaven Biopharma, Nasus Pharma, and more navigated drug–device integration, predictive preclinical and clinical translation, nose-to-brain delivery, regulatory pathways for combination products, investment strategy, and manufacturing scale-up. The agenda spans both liquid and powder-based approaches, with a strong emphasis on technical depth and future commercial readiness.
60+ nasal experts exchanged best practices, built high-value connections, and left with actionable strategies and partnerships to confidently accelerate their intranasal programs.
What You Missed
Attending Companies Included